<DOC>
	<DOCNO>NCT01882647</DOCNO>
	<brief_summary>This Phase 3 study design determine compare efficacy safety 000-0551 Lotion Vehicle Lotion apply twice daily two week subject plaque psoriasis .</brief_summary>
	<brief_title>A Comparison 000-0551 Lotion Versus Vehicle Lotion Subjects With Plaque Psoriasis ( Study -305 )</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Subject clinical diagnosis stable plaque psoriasis involve minimum 2 % 12 % affect body surface area . Subject Investigator 's Global Assessment ( IGA ) score least three ( moderate ) study start . If subject woman childbearing potential , must negative urine pregnancy test agree use effective form birth control duration study Subject spontaneously improve rapidly deteriorate plaque psoriasis . Subject guttate , pustular , erythrodermic nonplaque form psoriasis . Subject use phototherapy ( include laser ) , photochemotherapy form photo base therapy treatment psoriasis within 30 day prior study start . Subject use systemic methotrexate , retinoids , systemic corticosteroid [ include intralesional , intraarticular , intramuscular corticosteroid ] , cyclosporine analogous product within 90 day prior study start . Subject use systemic biologic therapy ( i.e. , FDAapproved experimental therapy ) within five halflives biologic prior study start . Subject prolonged exposure natural artificial source ultraviolet radiation within 30 day prior study start intending exposure study . Subject use topical body ( exclude scalp ) psoriasis therapy ( include coal tar , anthralin , steroid , retinoids , vitamin D analog ) within 14 day prior study start . Subject use emollients/moisturizers area treat within four hour prior clinical evaluation study start . Subject currently use lithium Plaquenil ( hydroxychloroquine ) . Subject currently use betablocking medication ( e.g. , propanolol ) angiotensin convert enzyme ( ACE ) inhibitor dose stabilize . Subject pregnant , lactating , plan become pregnant study . Subject currently enrol investigational drug device study . Subject use investigational drug investigational device treatment within 30 day prior study start . Subject previously enrol study treat test article .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>psoriasis</keyword>
	<keyword>lotion</keyword>
	<keyword>investigator 's global assessment</keyword>
</DOC>